Empagliflozin
Empagliflozin is the third inhibitor of the sodium-glucose co-transporter 2 to be approved for the treatment of adults with type 2 diabetes.
physical form & appearance:
Solid
Physical state:
Form:
Molecular weight:
Molecular formula:
Identification:
Assay:
Solubility:
Storage:
Technical Specification:
International non proprietary name:
Chemical Abstract Index Name:
Indication:
CAS Registry Number: